Molecular Mechanisms and Treatment Options of Nephropathic Cystinosis

Publication date

2021-07-01

Authors

Jamalpoor, AmerISNI 0000000492899198
Othman, Amr
Levtchenko, Elena N
Masereeuw, RosalindeORCID 0000-0002-1560-1074ISNI 0000000369326917
Janssen, M JORCID 0000-0002-0544-8096ISNI 0000000419454571

Editors

Advisors

Supervisors

Document Type

Article
Open Access logo

License

taverne

Abstract

Nephropathic cystinosis is a severe, monogenic systemic disorder that presents early in life and leads to progressive organ damage, particularly affecting the kidneys. It is caused by mutations in the CTNS gene, which encodes the lysosomal transporter cystinosin, resulting in intralysosomal accumulation of cystine. Recent studies demonstrated that the loss of cystinosin is associated with disrupted autophagy dynamics, accumulation of distorted mitochondria, and increased oxidative stress, leading to abnormal proliferation and dysfunction of kidney cells. We discuss these molecular mechanisms driving nephropathic cystinosis. Further, we consider how unravelling molecular mechanisms supports the identification and development of new strategies for cystinosis by the use of small molecules, biologicals, and genetic rescue of the disease in vitro and in vivo.

Keywords

CTNS gene, cystinosis, lysosomal storage disorder, renal Fanconi syndrome, therapeutic strategies, Taverne, Molecular Medicine, Molecular Biology

Citation

Jamalpoor, A, Othman, A, Levtchenko, E N, Masereeuw, R & Janssen, M J 2021, 'Molecular Mechanisms and Treatment Options of Nephropathic Cystinosis', Trends in Molecular Medicine, vol. 27, no. 7, pp. 673-686. https://doi.org/10.1016/j.molmed.2021.04.004